Dianthus Therapeutics Inc.(DNTH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DNTH Dianthus Therapeutics Inc.

盘后交易 01-20 16:52:19 EST

46.60

+2.50

+5.67%

盘后45.70

-0.90-1.93%

16:23 EST

最高46.76	最低42.70	成交量102.17万
今开42.83	昨收44.10	日振幅9.21%
总市值19.98亿	流通市值9.82亿	总股本4,288万
成交额4,664万	换手率4.85%	流通股本2,108万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DNTH","market":"US","secType":"STK","nameCN":"Dianthus Therapeutics Inc.","latestPrice":46.6,"timestamp":1768942800000,"preClose":44.1,"halted":0,"volume":1021708,"hourTrading":{"tag":"盘后","latestPrice":45.7,"preClose":46.6,"latestTime":"16:23 EST","volume":6722,"amount":313065.18484,"timestamp":1768944227673,"change":-0.9,"changeRate":-0.019313,"amplitude":0.019313},"delay":0,"changeRate":0.056689342403628114,"floatShares":21075200,"shares":42876015,"eps":-3.489224,"marketStatus":"盘后交易","change":2.5,"latestTime":"01-20 16:52:19 EST","open":42.83,"high":46.76,"low":42.7,"amount":46643034.05016,"amplitude":0.092063,"askPrice":47.51,"askSize":42,"bidPrice":45.7,"bidSize":43,"shortable":3,"etf":0,"ttmEps":-3.489224,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1768957200000},"marketStatusCode":4,"adr":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":44.1,"preHourTrading":{"tag":"盘前","latestPrice":43.1,"preClose":44.1,"latestTime":"09:12 EST","volume":67,"amount":2688.099965,"timestamp":1768918374105,"change":-1,"changeRate":-0.022676,"amplitude":0.094104},"postHourTrading":{"tag":"盘后","latestPrice":45.7,"preClose":46.6,"latestTime":"16:23 EST","volume":6722,"amount":313065.18484,"timestamp":1768944227673,"change":-0.9,"changeRate":-0.019313,"amplitude":0.019313},"volumeRatio":0.993902,"impliedVol":0.6249,"impliedVolPercentile":0.3984},"requestUrl":"/m/hq/s/DNTH","defaultTab":"news","newsList":[{"id":"1141035379","title":"维立志博与Dianthus Therapeutics宣布启动LBL-047（DNTH212）在健康志愿者和系统性红斑狼疮患者中的一期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1141035379","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141035379?lang=zh_cn&edition=full","pubTime":"2025-12-23 19:15","pubTimestamp":1766488533,"startTime":"0","endTime":"0","summary":"12月23日讯 - 南京维立志博（9887.HK）::*维立志博与Dianthus Therapeutics宣布启动LBL-047（DNTH212）在健康志愿者和系统性红斑狼疮（SLE）患者中的一期临床试验*南京维立志博有限公司：预计在2026年下半年公布健康志愿者的主要结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000252152.HKD","DNTH","BK4139","09887","HK0000500386.USD","HK0000252160.HKD"],"gpt_icon":0},{"id":"1161808614","title":"Leads Biolabs与Dianthus Therapeutics宣布在健康志愿者及系统性红斑狼疮患者中启动Lbl-047（Dnth212）一期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1161808614","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161808614?lang=zh_cn&edition=full","pubTime":"2025-12-23 19:04","pubTimestamp":1766487870,"startTime":"0","endTime":"0","summary":"Leads Biolabs与Dianthus Therapeutics宣布在健康志愿者及系统性红斑狼疮患者中启动Lbl-047（Dnth212）一期临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"1138872285","title":"Dianthus Therapeutics Inc. - 在获得Dnth212许可后预估现金余额为5.25亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138872285","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138872285?lang=zh_cn&edition=full","pubTime":"2025-10-16 19:04","pubTimestamp":1760612659,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc. - 在获得Dnth212许可后预估现金余额为5.25亿美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"1194605171","title":"Dianthus Therapeutics与Leads Biolabs达成独家许可协议，推出DNTH212——首个且可能是首屈一指的1期准备阶段双功能Bdca2及Baff/April抑制剂，针对重度自身免疫疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1194605171","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194605171?lang=zh_cn&edition=full","pubTime":"2025-10-16 19:01","pubTimestamp":1760612503,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics与Leads Biolabs达成独家许可协议，推出DNTH212——首个且可能是首屈一指的1期准备阶段双功能Bdca2及Baff/April抑制剂，针对重度自身免疫疾病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"1183776105","title":"Dianthus Therapeutics Inc.股价反转上涨，肌肉无力症治疗药物中期试验数据公布后涨幅达19.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183776105","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183776105?lang=zh_cn&edition=full","pubTime":"2025-09-08 23:46","pubTimestamp":1757346378,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc.股价出现反转走势，在公布其肌肉无力症治疗药物的中期试验数据后，股价最新上涨19.3%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"1118303138","title":"Dianthus Therapeutics Inc.公布Claseprubart(Dnth103)在全身性重症肌无力Magic 2期试验中的积极数据，支持其潜在同类最佳地位","url":"https://stock-news.laohu8.com/highlight/detail?id=1118303138","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118303138?lang=zh_cn&edition=full","pubTime":"2025-09-08 19:04","pubTimestamp":1757329470,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc.宣布，其药物候选产品Claseprubart(Dnth103)在针对全身性重症肌无力的Magic 2期临床试验中取得积极结果，这些数据进一步支持了该药物的潜在同类最佳特性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"1196326855","title":"异动解读 | Dianthus Therapeutics股价盘中大涨6.06%，尽管季度亏损略超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1196326855","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196326855?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:33","pubTimestamp":1754659985,"startTime":"0","endTime":"0","summary":"生物技术公司Dianthus Therapeutics Inc.今日盘中股价大涨6.06%，引起投资者广泛关注。这一涨幅出现在公司发布了截至6月30日的季度财报之后。根据财报，Dianthus Therapeutics报告调整后每股亏损88美分，略高于分析师预期的87美分亏损。值得注意的是，尽管营收超预期，但同比下降了89.6%。这种乐观情绪可能是推动股价上涨的另一个重要因素。此外，公司股价在本季度已上涨9.4%，显示出投资者对其长期发展前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DNTH"],"gpt_icon":0},{"id":"1148362510","title":"异动解读 | 季报喜忧参半，Dianthus Therapeutics盘中大涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148362510","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148362510?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:32","pubTimestamp":1754659965,"startTime":"0","endTime":"0","summary":"生物技术公司Dianthus Therapeutics Inc.今日盘中大涨6.06%，引起投资者广泛关注。这一涨幅出现在公司发布最新季度财报后，尽管财报结果喜忧参半。公司当季营收为19.3万美元，同比下降89.6%，净亏损达3163万美元。值得注意的是，分析师对Dianthus Therapeutics保持高度看好。这种强烈的看好情绪可能是推动股价上涨的主要因素。此外，公司股价本季度已上涨9.4%，尽管年初至今仍下跌6.5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DNTH"],"gpt_icon":0},{"id":"2557775593","title":"Dianthus Therapeutics, Inc.盘中异动 股价大跌5.05%报19.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557775593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557775593?lang=zh_cn&edition=full","pubTime":"2025-08-08 03:16","pubTimestamp":1754594215,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日03时16分，Dianthus Therapeutics, Inc.股票出现异动，股价急速下跌5.05%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段的生物技术公司，致力于设计和提供新型单克隆抗体，与现有的补体疗法相比，其选择性和效力更高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808031656973a3253&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808031656973a3253&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","BK4539","DNTH"],"gpt_icon":0},{"id":"2557230322","title":"Dianthus Therapeutics, Inc.盘中异动 早盘急速下跌6.14%报19.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557230322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557230322?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:44","pubTimestamp":1754491453,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时44分，Dianthus Therapeutics, Inc.股票出现波动，股价大幅跳水6.14%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段的生物技术公司，致力于设计和提供新型单克隆抗体，与现有的补体疗法相比，其选择性和效力更高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806224413a478f6b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806224413a478f6b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","DNTH","BK4007","BK4539"],"gpt_icon":0},{"id":"2517494669","title":"Dianthus Therapeutics, Inc.盘中异动 大幅拉升9.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517494669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517494669?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185055,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Dianthus Therapeutics, Inc.股票出现异动，股价急速拉升9.52%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223056abe9b05d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223056abe9b05d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DNTH","LENZ"],"gpt_icon":0},{"id":"2516308756","title":"Dianthus Therapeutics, Inc.盘中异动 早盘快速下挫5.00%报20.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516308756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516308756?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:07","pubTimestamp":1741014460,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时07分，Dianthus Therapeutics, Inc.股票出现波动，股价大幅下跌5.00%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230741989a1a32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230741989a1a32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNTH","BK4139","LENZ"],"gpt_icon":0},{"id":"2514387469","title":"Dianthus Therapeutics, Inc.盘中异动 临近午盘大幅拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514387469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514387469?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:40","pubTimestamp":1740674403,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时40分，Dianthus Therapeutics, Inc.股票出现异动，股价大幅拉升5.19%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228004003abdf8d22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228004003abdf8d22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DNTH","BK4139"],"gpt_icon":0},{"id":"2514566358","title":"Dianthus Therapeutics, Inc.盘中异动 早盘急速拉升7.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514566358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514566358?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580275,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分，Dianthus Therapeutics, Inc.股票出现异动，股价快速拉升7.80%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223115abddec78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223115abddec78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DNTH","BK4139"],"gpt_icon":0},{"id":"2513778530","title":"Dianthus Therapeutics, Inc.盘中异动 早盘快速跳水5.85%报22.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513778530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513778530?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:11","pubTimestamp":1740409876,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时11分，Dianthus Therapeutics, Inc.股票出现波动，股价急速跳水5.85%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231116a2521e62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231116a2521e62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","DNTH"],"gpt_icon":0},{"id":"2512481862","title":"Dianthus Therapeutics, Inc.盘中异动 早盘股价大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512481862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512481862?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:51","pubTimestamp":1739980266,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时51分，Dianthus Therapeutics, Inc.股票出现波动，股价快速跳水5.82%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235106abd50f87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235106abd50f87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DNTH","BK4139"],"gpt_icon":0},{"id":"2511815577","title":"Dianthus Therapeutics, Inc.盘中异动 临近收盘大幅拉升5.00%报24.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511815577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511815577?lang=zh_cn&edition=full","pubTime":"2025-02-14 05:00","pubTimestamp":1739480416,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日05时00分，Dianthus Therapeutics, Inc.股票出现波动，股价急速拉升5.00%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.20%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140500179884777e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140500179884777e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","DNTH"],"gpt_icon":0},{"id":"2509786830","title":"Dianthus Therapeutics, Inc.盘中异动 下午盘股价大跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509786830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509786830?lang=zh_cn&edition=full","pubTime":"2025-02-07 04:11","pubTimestamp":1738872676,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日04时11分，Dianthus Therapeutics, Inc.股票出现波动，股价快速下跌5.74%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207041116a23c1271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207041116a23c1271&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","DNTH"],"gpt_icon":0},{"id":"2509231487","title":"Dianthus Therapeutics, Inc.盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509231487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509231487?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:09","pubTimestamp":1738775373,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日01时09分，Dianthus Therapeutics, Inc.股票出现波动，股价快速拉升5.34%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.89%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206010934abc39f80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206010934abc39f80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNTH","LENZ","BK4139"],"gpt_icon":0},{"id":"2507961840","title":"Dianthus Therapeutics, Inc.盘中异动 早盘大幅上涨5.03%报22.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507961840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507961840?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:04","pubTimestamp":1738335861,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时04分，Dianthus Therapeutics, Inc.股票出现异动，股价快速上涨5.03%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312304229614ef31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312304229614ef31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNTH","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.magentatx.com","stockEarnings":[{"period":"1week","weight":0.1548},{"period":"1month","weight":0.0644},{"period":"3month","weight":0.237},{"period":"6month","weight":1.1618},{"period":"1year","weight":1.2957},{"period":"ytd","weight":0.0701}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Dianthus Therapeutics, Inc.于2015年6月17日根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，开发新药，为更多的患者带来骨髓移植的治疗能力。该公司打算成为移植医学领域的完全整合的发现，开发和商业公司。该公司相信产品组合将提供显著的商业协同效应。 该公司正在开发产品，以便可以单独使用或相互结合使用。因此，该公司的投资组合可以以适合患者疾病的方式使用，以便患者可以接受多于一种洋红疗法作为其个人移植旅程的一部分。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.147104},{"month":2,"riseRate":0.571429,"avgChangeRate":0.25232},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.018026},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.064022},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.056052},{"month":6,"riseRate":0.714286,"avgChangeRate":0.017401},{"month":7,"riseRate":0.625,"avgChangeRate":0.0311},{"month":8,"riseRate":0.5,"avgChangeRate":-0.011939},{"month":9,"riseRate":0.375,"avgChangeRate":0.056023},{"month":10,"riseRate":0.25,"avgChangeRate":-0.093611},{"month":11,"riseRate":0.5,"avgChangeRate":0.042669},{"month":12,"riseRate":0.25,"avgChangeRate":-0.158671}],"exchange":"NASDAQ","name":"Dianthus Therapeutics Inc.","nameEN":"Dianthus Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Dianthus Therapeutics Inc.(DNTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Dianthus Therapeutics Inc.(DNTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Dianthus Therapeutics Inc.,DNTH,Dianthus Therapeutics Inc.股票,Dianthus Therapeutics Inc.股票老虎,Dianthus Therapeutics Inc.股票老虎国际,Dianthus Therapeutics Inc.行情,Dianthus Therapeutics Inc.股票行情,Dianthus Therapeutics Inc.股价,Dianthus Therapeutics Inc.股市,Dianthus Therapeutics Inc.股票价格,Dianthus Therapeutics Inc.股票交易,Dianthus Therapeutics Inc.股票购买,Dianthus Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Dianthus Therapeutics Inc.(DNTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Dianthus Therapeutics Inc.(DNTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}